Literature DB >> 8097777

Immune response to nasal delivery of antigenically intact tetanus toxoid associated with poly(L-lactic acid) microspheres in rats, rabbits and guinea-pigs.

A J Almeida1, H O Alpar, M R Brown.   

Abstract

Tetanus toxoid was adsorbed onto poly(L-lactic acid) microspheres. Analyses by sodium dodecyl sulphate-polyacrylamide gel electrophoresis and Western blotting suggest that the formulation procedure does not affect the stability or the antigenic properties of the protein. After nasal administration to guinea-pigs, the resulting preparation enhanced the immune response to the tetanus toxoid when compared with the free antigen. The increase in systemic immunoglobulin G titre was almost immediate in the group treated with the adsorbed tetanus toxoid (time zero, 140; week 2, 1550; week 4, 2760), reaching 36,000 two weeks after the booster (week 7), whereas the free antigen produced an immune response similar to that found in non-treated animals. In a parallel experiment, latex particles of a similar size to poly(L-lactic acid) microspheres, administered to both rats and rabbits, were detected in the blood stream. These findings with tetanus toxoid demonstrate the use of microsphere delivery systems for nasal application of antigens. These had a profound effect on the immune response, and indicate possibilities for overcoming some of the barriers to drug absorption in general.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8097777     DOI: 10.1111/j.2042-7158.1993.tb05532.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  10 in total

1.  Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice.

Authors:  T Jung; W Kamm; A Breitenbach; K D Hungerer; E Hundt; T Kissel
Journal:  Pharm Res       Date:  2001-03       Impact factor: 4.200

Review 2.  Mucosal vaccines: recent progress in understanding the natural barriers.

Authors:  Olga Borges; Filipa Lebre; Dulce Bento; Gerrit Borchard; Hans E Junginger
Journal:  Pharm Res       Date:  2009-12-01       Impact factor: 4.200

3.  Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives.

Authors:  P Johansen; Y Men; R Audran; G Corradin; H P Merkle; B Gander
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

Review 4.  Modulating the immune system through nanotechnology.

Authors:  Tamara G Dacoba; Ana Olivera; Dolores Torres; José Crecente-Campo; María José Alonso
Journal:  Semin Immunol       Date:  2017-10-09       Impact factor: 11.130

5.  Uptake of microparticles into the epithelium of human nasopharyngeal lymphoid tissue.

Authors:  Yoshinori Fujimura; Takeshi Akisada; Tamotsu Harada; Ken Haruma
Journal:  Med Mol Morphol       Date:  2006-12-21       Impact factor: 2.309

6.  Immunogenicity and protection in small-animal models with controlled-release tetanus toxoid microparticles as a single-dose vaccine.

Authors:  M Singh; X M Li; H Wang; J P McGee; T Zamb; W Koff; C Y Wang; D T O'Hagan
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

7.  Stealth PLA-PEG nanoparticles as protein carriers for nasal administration.

Authors:  M Tobío; R Gref; A Sánchez; R Langer; M J Alonso
Journal:  Pharm Res       Date:  1998-02       Impact factor: 4.200

8.  Loading of tetanus toxoid to biodegradable nanoparticles from branched poly(sulfobutyl-polyvinyl alcohol)-g-(lactide-co-glycolide) nanoparticles by protein adsorption: a mechanistic study.

Authors:  Tobias Jung; Walter Kamm; Armin Breitenbach; Gerhard Klebe; Thomas Kissel
Journal:  Pharm Res       Date:  2002-08       Impact factor: 4.200

9.  Evaluation of mucoadhesive PLGA microparticles for nasal immunization.

Authors:  Dilip Pawar; Amit K Goyal; Sharad Mangal; Neeraj Mishra; Bhuvaneshwar Vaidya; Shailja Tiwari; Arvind K Jain; Suresh P Vyas
Journal:  AAPS J       Date:  2010-01-15       Impact factor: 4.009

Review 10.  Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery.

Authors:  Yeonhee Yun; Yong Woo Cho; Kinam Park
Journal:  Adv Drug Deliv Rev       Date:  2012-11-02       Impact factor: 15.470

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.